New CLL treatment approved
We are delighted to announce that NICE have approved acalabrutinib as a treatment for CLL.
Find out moreThis page was last reviewed 12th November 2024. Next review November 2027
Send us feedback about this pageSend us feedback about this page
Help us to ensure we deliver the best content we can by giving us feedback about this page, good or bad. Please provide an email address if you would like us to respond to your feedback.
"*" indicates required fields